SPi Global

Tag: COVID

Please see below all insights and news stories for this tag.

Safeguarding Drug Discovery and Trials Beyond the COVID-19 Crisis

Asset

Safeguarding Drug Discovery and Trials Beyond the COVID-19 Crisis

The Coronavirus disease (COVID-19) has triggered a rush of clinical trials to discover vaccines, threatening the continuity and success of non-COVID-19 drug discovery pipelines. This guide will help you learn to mitigate these new challenges, maintain pole position, and grow your business into the future with effective strategies for decentralization.

Read more

Contact Us

Any questions? Get in touch with us